Economic evaluation of blood stem-cells autologous transplantation

被引：0
作者：
Le Corroller, AG
Fortanier, C
Faucher, C
Blaise, D
Moatti, JP
机构：
[1] Inst J Paoli I Calmettes, INSERM 1, F-13273 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13273 Marseille, France
来源：
BULLETIN DU CANCER | 2001年 / 88卷 / 09期
关键词：
economics; blood cell; autologous transplantation; cost;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Economic evaluation of autologous peripheral blood stem cell (PBSC) transplantation certainly played a role in the very fast substitution from bone marrow to BC autograft. Economic evaluation is still ongoing about the optimization of the procedure by assessing the cost-effectiveness ratio of each new improvement of the technique. Among these improvements we present the administration of high dose CD34(+) cells, the delayed administration of G-CSF and the outpatient management of post-graft follow-up. It is still very rare in the field of health economics to notice such an early and ongoing economic evaluation of an innovation.
引用
收藏
页码：893 / 899
页数：7
相关论文
共 34 条
  • [1] A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation
    Barosi, G
    Marchetti, M
    Alessandrino, P
    Locatelli, F
    Casula, S
    Lunghi, M
    Cazzola, M
    Giraldi, E
    Bernasconi, C
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 719 - 725
  • [2] Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial
    Bolwell, BJ
    Pohlman, B
    Andresen, S
    Kalaycio, M
    Goormastic, M
    Wise, K
    Wakeling, A
    Dannley, R
    Overmoyer, B
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (04) : 369 - 373
  • [3] Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation
    Colby, C
    McAfee, SL
    Finkelstein, DM
    Spitzer, TR
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (10) : 1005 - 1010
  • [4] SUBSETS OF CD34(+) CELLS AND RAPID HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
    DERCKSEN, MW
    RODENHUIS, S
    DIRKSON, MKA
    SCHAASBERG, WP
    BAARS, JW
    VANDERWALL, E
    SLAPERCORTENBACH, ICM
    PINEDO, HM
    VONDEMBORNE, AEGK
    VANDERSCHOOT, CE
    GERRITSEN, WR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1922 - 1932
  • [5] Drummond M., 2015, METHODS EC EVALUATIO, V4
  • [6] Duncan N, 1996, BONE MARROW TRANSPL, V18, P1175
  • [7] Elien C, 2000, BLOOD, V96, p182A
  • [8] Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation - What is the optimal timing?
    Ener, RA
    Meglathery, SB
    Cuhaci, B
    Topolsky, D
    Styler, MJ
    Crilley, P
    Brodsky, I
    Kahn, SB
    King, RS
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (01): : 19 - 25
  • [9] Faucher C, 1996, J Hematother, V5, P663, DOI 10.1089/scd.1.1996.5.663
  • [10] FAUCHER C, 1994, BONE MARROW TRANSPL, V14, P895
1234